DENTSPLY SIRONA Inc. (XRAY): Price and Financial Metrics
DENTSPLY SIRONA Inc. (XRAY)
Today's Latest Price: $49.15 USD
Updated Oct 23 4:00pm
Add XRAY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 142 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
XRAY Stock Summary
- XRAY has a market capitalization of $9,978,730,223 -- more than approximately 84.27% of US stocks.
- With a one year PEG ratio of 233.11, DENTSPLY SIRONA Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 85.67% of US stocks.
- DENTSPLY SIRONA Inc's stock had its IPO on April 25, 1991, making it an older stock than 83.61% of US equities in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to DENTSPLY SIRONA Inc are BRO, IVZ, WRB, ESE, and BEN.
- Visit XRAY's SEC page to see the company's official filings. To visit the company's web site, go to www.dentsplysirona.com.
XRAY Stock Price Chart Interactive Chart >
XRAY Price/Volume Stats
| Current price | $49.15 | 52-week high | $60.87 |
| Prev. close | $48.34 | 52-week low | $31.58 |
| Day low | $48.18 | Volume | 1,633,900 |
| Day high | $49.58 | Avg. volume | 1,944,300 |
| 50-day MA | $44.68 | Dividend yield | 0.81% |
| 200-day MA | $45.42 | Market Cap | 10.74B |
DENTSPLY SIRONA Inc. (XRAY) Company Bio
DENTSPLY International designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company was founded in 1899 and is based in York, Pennsylvania.
XRAY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $49.15 | $18.63 | -59% |
We started the process of determining a valid price forecast for DENTSPLY SIRONA Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that DENTSPLY SIRONA Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for DENTSPLY SIRONA Inc ended up being:
- The compound growth rate in the free cash flow of DENTSPLY SIRONA Inc over the past 5.46 years is 0.03%; that's better than only 22.75% of cash flow producing equities in the Healthcare sector, where it is classified.
- DENTSPLY SIRONA Inc's effective tax rate, as measured by taxes paid relative to net income, is at 62 -- greater than 95.46% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -60% |
| 1% | -60% |
| 2% | -59% |
| 3% | -59% |
| 4% | -58% |
| 5% | -58% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as XRAY, try RMD, IONS, JNJ, ENTA, and A.
Loading social stream, please wait...